\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesOn 20 december 24 the President of the European Commission Ursula von der Leyen and the President of the Swiss Confederation Viola Amherd confirmed the completion of negotiations on a broad package of agreements that aim to deepen and expand the EU-Switzerland relationship. More detials on this press release.
A transitional arrangement allows researchers and innovators in Switzerland to participate in almost all calls for proposals of Horizon Europe, the Euratom programme and Digital Europe, from the 2025 programme year onwards. They can apply as beneficiaries in almost all calls. The budget of the Swiss partner must be included in the total grant amount that the consortium is requesting from the EU.
Though be aware of the following.
This webpage of SERI (the Swiss State Secretariat for Education, Research and Innovation) gives details about the transitional measures, including an elaborated FAQ page.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
